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Background: Obesity and metabolic syndrome play causative roles in the increasing prevalence of proteinuria in
the general population. However, in young adult women the clinical significance of incidentally discovered
proteinuria and its association with metabolic syndrome are unclear. We investigated the prevalence and risk
factors for proteinuria in this population.
Methods: A total of 10,385 women aged 20 to 39 years who underwent health screenings were surveyed. Each
patient was tested for proteinuria with a dipstick (−, ±, 1+, 2+, or 3+), and proteinuria was defined as 1+ or greater.
Persistent proteinuria was established by confirming proteinuria in a subsequent test. Metabolic syndrome was
defined in accordance with the updated National Cholesterol Education Program Adult Treatment Panel III criteria
for Asia.
Results: The mean age was 28.9 ± 5.5 years, and the prevalence of persistent proteinuria was 1.0%. Among these
subjects with persistent proteinuria, obesity and metabolic syndrome were found in 10.4% and 5.2%, respectively.
Metabolic syndrome, as well as its components of hypertension, hyperglycemia, central obesity, low high-density
lipoprotein levels, and high triglyceride levels, was closely related to the presence of proteinuria. In addition, a wide
pulse pressure of ≥40 mmHg was another independent risk factor for proteinuria [odds ratio (OR) 3.29, 95%
confidence interval (CI) 1.03–11.91)]. This had an additive effect on metabolic syndrome in terms of predicting
proteinuria. Even in subjects without metabolic syndrome, the influence of an increased pulse pressure was
consistent (OR 2.75, 95% CI 1.03–8.61).
Conclusions: Specific attention to proteinuria may be necessary in asymptomatic young women aged 20 to
39 years if they have metabolic syndrome or a wide pulse pressure.Background
Proteinuria is a common laboratory finding in the gen-
eral population. Although it is transient and functional
in most cases, persistent proteinuria may be an inde-
pendent risk factor for adverse renal and cardiovascular
outcomes [1-4]. In clinical practice, nevertheless, inci-
dentally discovered proteinuria in young adults aged 20
to 39 years is often overlooked as benign proteinuria. In
fact, the Third National Health and Nutrition Examination
Survey (NHANES III) in the United States reported that* Correspondence: imnksk@gmail.com
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reproduction in any medium, provided the orthe prevalence of overt proteinuria (urine albumin-to-cre-
atinine ratio [UACR] ≥ 300 mg/L) in this age group was
0.5% in males and 0.9% in females, and the relative fre-
quency of an abnormal UACR of ≥30 mg/L was 6.5% and
8.1%, respectively, the lowest among all age groups [5].
Therefore, the cost-effectiveness and benefit of screening
for proteinuria in young individuals without symptoms or
relevant associated diseases such as diabetes or hyperten-
sion is debatable.
Metabolic syndrome, which comprises central obesity,
dyslipidemia, high blood pressure (BP), and impaired
fasting glucose, is a known risk factor for proteinuria in
the general population [6,7]. Recently, the increasing
prevalence of obesity has affected the increase in meta-
bolic syndrome and glomerulopathy [8]. However, most. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and proteinuria were conducted in subjects over 40 years
of age [9,10], and comparatively little is known in youn-
ger population.
Especially in young women aged 20 to 39 years, clinical
proteinuria could be a critical issue because unrecognized
or ignored pre-pregnancy proteinuria could induce many
complications during pregnancy, from urinary tract infec-
tion (UTI) to chronic kidney disease, and it remains cen-
tral to the diagnosis of preeclampsia in hypertensive
pregnancy [11]. In addition, previous investigators found
that even mild intermittent proteinuria in asymptomatic
young individuals is frequently associated with significant
underlying renal pathology, emphasizing that it may not
be a benign condition [12].
Therefore, we evaluated the association between meta-
bolic syndrome and proteinuria in this young female
population and investigated additional risk factors for
proteinuria.
Methods
Subjects and health screenings parameters
A total of 10,724 young women aged 20–39 years who
underwent health screenings at Hallym University Sacred
Heart Hospital from January 2010 to December 2011 were
enrolled. Among those, medical records were available for
10,472 subjects. To exclude the possibility of false-positive
results, alkaline (pH ≥8, n = 39) or highly concentrated
(specific gravity >1.025, n = 33) specimens were excluded.
Individuals with pre-diagnosed CKD (n = 15) was also ex-
cluded. Thus, the data of 10,385 subjects were analyzed.
This study was performed with the approval of the local
Institutional Review Board.
The health screening examination included 1) an
interview regarding current health status (diabetes,
hypertension, alcohol, smoking, exercise, medication,
marital status, and childbirth), 2) a physical examination -
height, weight, waist circumference, body mass index
(BMI) and blood pressure (BP) 3) blood and urine tests.
Waist circumference was measured to the nearest
0.1 cm in a horizontal plane at the level of the midpoint
between the iliac crest and the costal margin at the end
of a normal expiration. The BMI was calculated as the
individual’s weight (kg) divided by the square of the
height (m), and obesity was defined as BMI ≥25 kg/m2.
All blood samples were obtained in the fasting state.
The serum levels of hemoglobin, glucose, total cholesterol
(TC), high-density lipoprotein (HDL) cholesterol, triglyc-
erides (TG), and creatinine were measured. Low-density
lipoprotein (LDL) cholesterol was calculated using the
following equation; LDL = TC – HDL – TG/5.0 (mg/dL).
Glomerular filtration rate (GFR) was assessed using
2 estimating equations, Modification of Diet in Renal
Disease (MDRD) Study equations and CKD EpidemiologyCollaboration (CKD-EPI) equations [13]. Metabolic syn-
drome was defined in accordance with the updated
National Cholesterol Education Program Adult Treatment
Panel (NCEP-ATP) III criteria [14]. Particularly in our
study, waist criteria for Asian people were used [15,16].
The presence of three or more of the following criteria
constituted a diagnosis of metabolic syndrome: (i) waist
circumference ≥80 cm; (ii) fasting triglyceride ≥150 mg/dL
or medication use; (iii) HDL cholesterol < 50 mg/dL or
medication use; (iv) BP ≥130/85 mmHg or antihyperten-
sive medication use; and (v) fasting glucose ≥100 mg/dL
or current medication.Proteinuria evaluation
Dipstick urinalysis was performed using spontaneously
voided fresh urine that was analyzed within a few mi-
nutes after collection. Urinalysis was not performed in
subjects who were menstruating or exhibiting symp-
toms of UTI or vaginal discharge. The results were
interpreted by one physician and were scored as (−)
when no staining was observed, (±) when weak staining
was observed, and 1+, 2+, 3+, or 4+ when mild-to-strong
staining was observed. Proteinuria was defined as 1+ or
greater. However, the quantification of proteinuria was
not performed in the routine screening test. For pa-
tients who had proteinuria at the initial test, follow-up
test was recommended within 1 or 2 weeks. Persistent
proteinuria was confirmed when repeat testing also re-
vealed proteinuria ≥1+. For second test, proteinuria
was quantified using protein-to-creatinine ratio (UPCR)
and albumin-to-creatinine ratio (UACR). The clinical
diagnosis of proteinuria was made by each physician
based on previous history, clinical features, and labora-
tory findings regardless of whether a renal biopsy was
performed or not.Statistical analysis
Statistical analyses were performed using SPSS version
18.0 (SPSS Inc., Chicago, IL, USA). All variables were
expressed as the mean ± SD or median with ranges, un-
less otherwise indicated. Differences between two groups
were analyzed by an independent t-test for continuous
variables or the Fischer’s exact test for categorical data.
The receiver operating characteristics (ROC) curve was
constructed for evaluating the relationship between
pulse pressure and proteinuria and the areas under the
curve (AUC) were calculated. Multiple logistic regres-
sion analysis was performed to find significant determi-
nants for proteinuria. In multivariate models, age,
smoking, BMI, systolic BP, pulse pressure, cholesterol,
presence of metabolic syndrome and eGFRCKD-EPI were
included. P < 0.05 was considered statistically significant.
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Baseline characteristics
The mean subject age was 28.9 ± 5.5 years, 6791 (65.3%)
had a history of childbirth, and 1515 (14.6%) had been
taking medication for dysmenorrhea. In the initial urin-
ary dipstick test, 227 (2.2%) subjects had varying degrees
of proteinuria: 1+ (n = 184, 1.8%), 2+ (n = 40, 0.4%), and
3+ (n = 3, 0.03%). Of these, a repeat test was performed
in 209 subjects; 97 showed persistent proteinuria, but
112 had no proteinuria in the second urinalysis
(Figure 1). Therefore, the prevalence of persistent pro-
teinuria in young females aged 20 to 39 years was 1.0%.
The median UPCR and UACR measured in repeat urin-
alysis were 0.57 and 0.45, respectively, in subjects with
persistent proteinuria.
The baseline demographic and laboratory findings
according to the presence of proteinuria are shown in
Table 1. Persistent proteinuria was more prevalent in
current or past smokers. In addition, subjects with pro-
teinuria had a higher BMI, waist circumference, systolic
BP, and wide pulse pressure. Baseline renal function,
both the eGFRCKD-EPI and eGFRMDRD, were significantly
lower in subjects with proteinuria, too. In addition,
serum levels of metabolic components, fasting glucose,
TG, and HDL were significantly different between the
two groups.
Prevalence of proteinuria and risk factor analysis
Among the young women in this study, the prevalence
of obesity and metabolic syndrome were 10.4% and
5.2%, respectively. The prevalence of proteinuria wasFigure 1 Flow diagram of proteinuria evaluation. The prevalence of pehigher in subjects with a BMI ≥25 kg/m2 compared with
those with a BMI <25 kg/m2 (3.2% vs. 0.7%, respectively;
p < 0.001) (Figure 2, upper). And proteinuria was detected
more frequently in subjects with metabolic syndrome than
in those without (24.5% vs. 0.7%, respectively; p < 0.001),
and the prevalence increased significantly as the number
of metabolic components increased (Figure 2, lower). In
Figure 3, the unadjusted odds ratio (OR) for proteinuria
according to each metabolic component is shown. Signifi-
cantly higher rates of proteinuria were observed across all
categories of metabolic components.
Furthermore, an increased pulse pressure was another
important risk factor for proteinuria in these subjects. A
1-mmHg increase in pulse pressure was associated with
a 10% increased risk of having proteinuria (OR 1.10, 95%
CI 1.067–1.137, p < 0.001), and the ROC curve analysis
showed a close relationship between pulse pressure and
proteinuria (Figure 4). The area under the ROC curve
was 0.754, and with a cut-off value of 40 mmHg, the
sensitivity and specificity were 0.91 and 0.84, respect-
ively. When subjects were stratified into four groups
according to the presence of metabolic syndrome and
pulse pressure (≥40 or <40 mmHg), the risk of protein-
uria was highest in those with both metabolic syndrome
and high pulse pressure (relative risk, 13.03) (Figure 5).
Table 2 shows the clinical factors associated with pro-
teinuria in this young female population. Smoking, a
BMI of ≥25, systolic BP of ≥110 mmHg, pulse pressure
of ≥40 mmHg, and the presence of metabolic syndrome
were associated with proteinuria in the univariate ana-
lysis. In the multivariate analysis, only a pulse pressurersistent proteinuria was 1% in young women of general population.
Table 1 Baseline characteristics of the study subjects
Total* Persistent proteinuria
Negative Positive P
Number, n (%) 10367 10270 97 -
Age (years) 28.9 ± 5.5 28.8 ± 5.5 29.3 ± 5.5 0.572
Smoker, n (%) <0.001
Ex-smoker 95 (0.9) 87 (0.8) 8 (8.2)
Current 102 (1.0) 93 (0.9) 9 (9.2)
Height (cm) 161.5 ± 4.9 161.4 ± 4.9 162.4 ± 5.1 0.243
Weight (kg) 54.5 ± 8.5 54.0 ± 7.9 60.0 ± 12.4 <0.001
BMI (kg/m2) 20.9 ± 3.2 20.7 ± 2.9 23.2 ± 4.8 <0.001
Waist circumference (cm) 69.6 ± 7.3 69.3 ± 6.6 74.2 ± 11.6 <0.001
Systolic BP (mmHg) 107.0 ± 11.4 105.0 ± 10.9 118.1 ± 12.4 <0.001
Diastolic BP (mmHg) 66.7 ± 8.9 66.7 ± 9.0 66.3 ± 8.2 0.765
Pulse pressure (mmHg) 43.3 ± 9.3 38.4 ± 8.7 51.8 ± 11.1 <0.001
Hemoglobin (g/dL) 12.7 ± 0.9 12.7 ± 0.9 12.8 ± 1.2 0.552
Fasting glucose (mg/dL) 86.5 ± 13.3 85.7 ± 10.8 95.6 ± 28.5 <0.001
Serum creatinine (mg/dL) 0.66 ± 0.10 0.64 ± 0.09 0.70 ± 0.15 0.013
Estimated GFR
CKD-EPI (mL/min/1.73 m2) 117.6 ± 10.8 117.7 ± 10.7 111.5 ± 17.1 <0.001
MDRD Study (mL/min/1.73 m2) 110.9 ± 33.1 111.0 ± 33.1 101.3 ± 23.2 0.048
Total cholesterol (mg/dL) 178.8 ± 29.4 177.8 ± 29.0 189.1 ± 31.7 0.015
HDL cholesterol (mg/dL) 67.6 ± 18.3 68.2 ± 18.5 62.2 ± 15.8 0.040
LDL cholesterol (mg/dL) 95.7 ± 27.3 94.7 ± 26.8 106.9 ± 30.7 0.006
Triglyceride (mg/dL) 78.0 ± 36.8 75.5 ± 35.0 104.7 ± 45.1 <0.001
UACR (mg/g) - - 0.45 (0.26-2.6) -
UPCR (mg/g) - - 0.57 (0.31-3.6) -
Blood on dipstick test, n (%) 0.015
None 8558 (82.6%) 8495 (82.7%) 63 (64.9%)
Trace 1540 (14.8%) 1534 (14.9%) 6 (6.3%)
Positive 269 (2.5%) 241 (2.3%) 28 (28.8%)
*Total: All screening subjects (n = 10,385) – subjects without repeat urinalysis (n = 18).
Abbreviations: BMI, body mass index; BP, blood pressure; GFR, glomerular filtration rate; CKD-EPI, CKD-Epidemiology Collaboration; MDRD Study equation,
Modification of Diet in Renal Disease Study equation; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UACR, urine albumin-to-creatinine ratio; UPCR,
urine protein-to-creatinine ratio.
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syndrome (OR 7.77, 95% CI 3.27–18.44) were significant
determinants of proteinuria.
In the subgroup of subjects without metabolic syn-
drome, the prevalence of proteinuria was 0.7%. Smoking,
a BMI ≥25, and a systolic BP ≥110 mmHg did not influ-
ence the presence of proteinuria. However, the effect of
a wide pulse pressure was consistent even in subjects
without metabolic syndrome (OR 2.75, 95% CI 1.03–8.61).
Discussion
In the present study, we evaluated the prevalence of,
and factors associated with, proteinuria in the generalpopulation, especially young women aged 20 to 39 years.
We found that 1.0% of this population had persistent
proteinuria, and metabolic syndrome as well as its com-
ponents of hypertension, hyperglycemia, central obesity,
low HDL levels, and high TG levels was closely related
to the presence of proteinuria. In addition, a wide pulse
pressure ≥40 mmHg was another important risk factor
for proteinuria. The effect of a wide pulse pressure was
independent of other clinical factors, including meta-
bolic components. Even in subjects without metabolic
syndrome, the influence of a wide pulse pressure on
proteinuria was consistent. Therefore, specific attention
may be necessary in asymptomatic young women if they
Figure 2 The prevalence of proteinuria in subjects with obesity
and metabolic syndrome. The prevalence of proteinuria was
significantly higher in obese patients, and the prevalence increased
significantly as the number of metabolic components increased.
Figure 4 ROC curve. Pulse pressure of 40 mmHg maximizes the
prediction of proteinuria (sensitivity of 91.2% and specificity of
84.4%). Area under the curve = 0.754.
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our knowledge, this is the first report of risk factors for
proteinuria in young adult women.
In clinical practice, incidentally discovered proteinuria in
young healthy adults is often ignored or overlooked. In-
deed, according to a review article published two decades
ago, proteinuria screening in healthy, asymptomatic adultsFigure 3 Unadjusted odds ratio for proteinuria according to each me
observed across all categories of metabolic components.was not recommended because less than 1.5% of subjects
with positive dipstick findings had significant disease.
However, they mentioned that proteinuria screening could
detect many cases of potentially significant disease, such as
mild glomerulonephritis or renal impairment [17]. More-
over, Muth et al. reported that proteinuria, even intermit-
tent proteinuria, might not be a benign condition. They
biopsied 51 young asymptomatic patients with intermittent
proteinuria and normal renal function (age, 16–34 years)
and found that approximately two-thirds of patients had
pathologic evidence of renal disease [12]. As these data
show, proteinuria in young adults may not be as benign as
previously thought. Nevertheless, the recommendation oftabolic component. Significantly higher rates of proteinuria were
Figure 5 Subjects with both metabolic syndrome and elevated
pulse pressure showed the highest relative risk for proteinuria
in the general young population.
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eral young population seems unreasonable because it is
cost-ineffective. Therefore, early identification of risk fac-
tors for persistent proteinuria is important.
According to our data, the prevalence of incidentally
discovered proteinuria was 2.2%, and half of those sub-
jects had persistent proteinuria. Thus, the prevalence of
persistent proteinuria was 1.0%, similar to previous re-
ports [5]. Metabolic syndrome and its components were
closely associated with persistent proteinuria. Metabolic
syndrome, a clustering of various metabolic derange-
ments, is a well-established independent predictor of
cardiovascular morbidity and mortality in the general
population [6,8,9,18,19]. In addition, a close relationship
between metabolic syndrome and the development of
proteinuria has been reported. Lucove et al. reported a
1.26-fold increased risk for the development of proteinuriaTable 2 Univariate and multivariate analysis for prediction of
Univariate analysis
OR (95% CI) P
Total patients
Smoking 1.33 (1.06-6.83) 0.002
BMI≥ 25 4.34 (2.05-9.18) <0.001
Systolic BP≥ 110 mmHg 2.39 (1.20-4.76) 0.013
Pulse pressure≥ 40 mmHg 5.01 (1.53-16.58) 0.008
Metabolic syndrome 10.65 (5.10-27.96) <0.001
Without metabolic syndrome
Smoking 1.26 (0.58-3.66) 0.216
BMI≥ 25 1.50 (0.43-5.23) 0.525
Systolic BP≥ 110 mmHg 2.07 (0.95-4.50) 0.085
Pulse pressure≥ 40 mmHg 3.68 (1.10-12.30) 0.032
* adjusted for age, smoking, BMI, systolic BP, pulse pressure, cholesterol, and presen
† adjusted for age, smoking, BMI, systolic BP, pulse pressure, cholesterol, presence oamong American Indians with metabolic syndrome [9].
Tozawa et al. also reported the effect of metabolic syn-
drome in a Japanese population (relative risk 2.09) [3].
Moreover, similar findings were observed in the general
Korean population (OR 2.30). However, these prior studies
included subjects over 40 years of age, and their signifi-
cance in the young population is unknown. According to
our data, in young subjects aged 20 to 39 years, metabolic
syndrome was associated with an eightfold increased risk
of persistent proteinuria. Several mechanisms, including
insulin resistance, chronic inflammation, and lipotoxicity,
have been proposed to explain the diverse renal effects of
metabolic syndrome [20]. Various adipocytokines also
play important roles in renal damage by inducing sym-
pathetic overactivity, systemic inflammation, and oxida-
tive stress [21]. Considering that metabolic syndrome is
a modifiable risk factor, early detection and treatment of
metabolic syndrome would be a cost-effective strategy
to decrease the prevalence of proteinuria as well as
chronic kidney disease and end-stage renal disease in
the general population.
Another important finding of our study is that subjects
with persistent proteinuria had a higher systolic BP and
wider pulse pressure than those without persistent pro-
teinuria. In particular, the pulse pressure was closely as-
sociated with proteinuria, and its effect was independent
to other clinical factors. Generally in postmenopausal fe-
males, the loss of estrogenic action on the arterial wall
appears to play a specific deleterious role by increasing
arterial stiffness and pulse pressure [22,23]. Therefore,
cardiovascular complications are more common in males
and postmenopausal females than in premenopausal fe-
males. However, in this study, we found a harmful effect of
an increased pulse pressure in young healthy women aged
20 to 39 years; therefore, our findings could emphasize theproteinuria
Multivariate analysis* Multivariate analysis†
OR (95% CI) P OR (95% CI) P
1.12 (0.78-2.59) 0.191 1.11 (0.59-1.66) 0.397
1.61 (0.62-4.20) 0.262 1.53 (0.65-3.60) 0.321
1.69 (0.83-3.46) 0.145 1.64 (0.80-3.36) 0.174
3.89 (1.08-10.36) 0.026 3.29 (1.03-11.91) 0.043
7.99 (3.43-18.60) <0.001 7.77 (3.27-18.44) <0.001
1.04 (0.54-2.35) 0.612 1.05 (0.54-3.05) 0.619
1.20 (0.36-4.02) 0.770 1.19 (0.35-4.01) 0.777
1.63 (0.73-3.62) 0.230 1.49 (0.74-3.64) 0.225
2.89 (1.04-9.64) 0.038 2.75 (1.03-8.61) 0.041
ce of metabolic syndrome.
f metabolic syndrome and eGFRCKD-EPI.
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to other risk factors such as aging process or hormonal
changes. Our results are consistent with previous longitu-
dinal data suggesting that pulse pressure is a risk factor for
increased albuminuria in general or hypertensive athero-
sclerotic populations [24,25]. The close association be-
tween an increased pulse pressure and proteinuria could
be explained by the fact that a wide pulse pressure induces
endothelial dysfunction and barotrauma of the renal arter-
ies [26-29]. However, due to the limitation of the present
cross-sectional design, the causal relationship between
proteinuria and wide pulse pressure among this young
population without vascular risk factors could not be
exactly identified. Moreover, a recent large-scale Japanese
study reported that close associations between high pulse
pressures and proteinuria could be established only in
diabetic patients, not among subjects with prediabetes or
normal glucose tolerance [30]. Therefore, a further well-
designed study is needed to elucidate the pathophysio-
logical link between pulse pressure and proteinuria in the
young adult population.
The association between an increased pulse pressure
and metabolic syndrome is also unclear; however, several
studies investigated the relationship between pulse pres-
sure and metabolic syndrome. Ferreira et al. reported
that young individuals with metabolic syndrome have in-
creased arterial stiffness because of poor cardiopulmo-
nary fitness and high subcutaneous trunk fat [31]. The
researchers suggested increased arterial stiffness as a risk
factor for cardiovascular disease in subjects with meta-
bolic syndrome. However, there is also a contrary opin-
ion. According to a study by Mannucci et al., the close
association between high pulse pressure and metabolic
syndrome disappeared after adjustment for age and mean
BP [32]. In our study, pulse pressure was closely associ-
ated with waist circumference, BMI, and TG levels, but
not with HDL and glucose levels. Therefore, additional fu-
ture data on this relationship are needed, too.
This study has several weaknesses. First, although the
medical chart of each patient was thoroughly reviewed,
it is impossible to review the precise history of past med-
ical conditions, especially those affecting proteinuria, in all
patients. Because the survey was a self-reported question-
naire, patients who were reluctant to report their medical
conditions or drug history may not have provided com-
pletely accurate information. Moreover, we could not
check several laboratory parameters that are known to be
associated with proteinuria, such as the uric acid or C-
reactive protein levels, because of the limitation of the
health screening data. Second, of those with persistent
proteinuria, only 53.6% were referred to a nephrologist
and renal biopsy was performed only in a minority of pa-
tients; therefore, we were unable to identify the exact
pathological diagnosis of persistent proteinuria.Conclusions
Of the young women aged 20 to 39 years in this study,
1.0% exhibited persistent proteinuria. Metabolic syn-
drome and its components of hypertension, hypergly-
cemia, central obesity, low HDL levels, and high TG
levels were closely related to the presence of proteinuria.
In addition, an increased pulse pressure may be an im-
portant independent risk factor for proteinuria; indeed,
it exhibited an additive effect with metabolic syndrome
for prediction of proteinuria. Specific attention to pro-
teinuria may be necessary in asymptomatic young women
aged 20 to 39 years if they have metabolic syndrome or a
wide pulse pressure.
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